Author's posts
China Stocks Routed Amid Growth Worries; Alibaba Drops 4.5% After Surprise Leadership Switch
Billions of dollars of market capitalization in China shares wiped out
China Pharma Billionaire Adds To Fortune Following Genrix Listing In Shanghai
Antibody drug supplier fell in early trade
China Lands 15 Venture Investors On 2023 Forbes Midas List
China ranked second only to the U.S. with most listees
China Billionaire’s Grand Pharma Buys BlackSwan Vascular For $37.5 Million
Global market eyed
BeiGene Expects To Finish Construction At $700 Million New Jersey Site In 2024
BeiGene aims to tap the area’s life sciences talent pool.
Four Elements Of Healthcare Industry Leadership: Forbes China Summit
“Healthcare can often be a very conservative industry because it’s an industry that deals with very long timetables. However, playing it too safe and too careful can leave you behind competitors,” Forbes Senior Editor Alex Knapp believes.
U.S.-China Collaboration Could Cut Development Time, Cost For New Cancer Treatments
The world’s current system for developing cancer drugs is unsustainable, Memorial Sloan Kettering oncologist Dr. Bob Li believes.
Harness Uncertainty To Overcome It In Today’s Business World: Forbes China Summit
In today’s uncertain times, business leaders should focus on what is certain in their environment as a key approach to success, University of Michigan Business Professor told a Forbes China gathering last week
Cancer Drug Supplier’s IPO Mints China’s Latest Billionaire
China and the U.S. rank No. 1 and No. 2 in the number of cancer patients and overall cancer burden.
Nearly 28% Of Mainland China Arrivals At Taiwan’s Busiest Airport Test Positive For Covid Sunday
A wave of Covid outbreaks in mainland China are leading to increased testing of travelers from the country.
